Models of metastasis in drug discovery

Methods in Molecular Biology

Volumn 602, Issue , 2010, Pages 215-233

  Talmadge, James E ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

autochthonous tumors; genetically engineered tumor models; Metastasis; orthotopic tumors; spontaneous metastasis

Indexed keywords

ANIMALIA;

AGED; ANIMAL; ARTICLE; CANCER TRANSPLANTATION; DISEASE MODEL; DRUG DEVELOPMENT; DRUG SCREENING; GENETICS; HUMAN; METASTASIS; METHODOLOGY; NEOPLASM; PATHOLOGY; TUMOR CELL LINE;

AGED, 80 AND OVER; ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DRUG DISCOVERY; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASMS;

EID: 77449131744     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60761-058-8_13     Document Type: Article

References (41)

1. Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C. and Thun, M. J. (2006) Cancer statistics, 2006. CA Cancer J Clin 56, 106-130.
2. Talmadge, J. E., Wolman, S. R. and Fidler, I. J. (1982) Evidence for the clonal origin of spontaneous metastases. Science 217, 361-363. (Pubitemid 12090734)
3. Talmadge, J. E. and Fidler, I. J. (1982) Cancer metastasis is selective or random depending on the parent tumour population. Nature 297, 593-594. (Pubitemid 12027627)
4. Talmadge, J. E., Benedict, K., Madsen, J. and Fidler, I. J. (1984) Development of biological diversity and susceptibility to chemotherapy in murine cancer metastases. Cancer Res 44, 3801-3805. (Pubitemid 14041594)
5. Fidler, I. J. (1991) Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for the biology and therapy of metastasis. Cancer Metastasis Rev 10, 229-243.
6. Hoffman, R. M. (1999) Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest New Drugs 17, 343-359. (Pubitemid 30135902)
7. Hoffman, R. M. (1997) Fertile seed and rich soil: development of patient-like models of human cancer by surgical orthotopic implantation of intact tissue, in update series: comprehensive textbook of oncology, Vol. 4 Schimpff, S. C. et al. (eds.), Williams & Wilkins, Baltimore, pp 127-144.
8. Killion, J. J, Radinsky, R. and Fidler, I. J. (1999) Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metastasis Rev 17, 279-284. (Pubitemid 29210167)
9. Dexter, D. L., Diamond, M., Creveling, J. and Chen, S. F. (1993) Chemotherapy of mammary carcinomas arising in ras transgenic mice. Invest New Drugs 11, 161-168. (Pubitemid 23277236)
10. Moser, A. R., Hegge, L. F. and Cardiff, R. D. (2001) Genetic background affects susceptibility to mammary hyperplasias and carcinomas in Apc(min)/+ mice. Cancer Res 61, 3480-3485. (Pubitemid 32695044)
11. Zeidman, I., McCutcheon, M. and Coman, D. R. (1950) Factors affecting the number of tumor metastases; experiments with a transplantable mouse tumor. Cancer Res 10, 357-359.
12. Fisher, B. and Fisher, E. R. (1968) Role of host and tumor calcium in metastases. Cancer Res 28, 1753-1758.
13. Liotta, L. A., Saidel, M. G. and Kleinerman, J. (1976) The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res 36, 889-894.
14. Fidler, I. J. and Talmadge, J. E. (1978) Methods in cancer research, in preclinical screeing, Vol. 2, Academic Press.
15. Hart, I. R., Talmadge, J. E. and Fidler, I. J. (1983) Comparative studies on the quantitative analysis of experimental metastatic capacity. Cancer Res 43, 400-402. (Pubitemid 13172848)
16. Fidler, I. J. (1980) Therapy of spontaneous metastases by intravenous injection of liposomes containing lymphokines. Science 208, 1469-1471. (Pubitemid 10022196)
17. Donawho, C. K., Pride, M. W. and Kripke, M. L. (2001) Persistence of immunogenic pulmonary metastases in the presence of protective anti-melanoma immunity. Cancer Res 61, 215-221. (Pubitemid 32095720)
18. Rebhun, R. B., Lazar, A. J., Fidler, I. J. and Gershenwald, J. E. (2008) Impact of sentinel lymphadenectomy on survival in a murine model of melanoma. Clin Exp Metastasis 25, 191-199.
19. Brinster, R. L., Chen, H. Y., Messing, A., Van, D. T., Levine, A. J. and Palmiter, R. D. (1984) Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell 37, 367-379. (Pubitemid 14079032)
20. Heineke, J. and Molkentin, J. D. (2006) Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7, 589-600. (Pubitemid 44325350)
21. Gossen, M. and Bujard, H. (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89, 5547-5551.
22. Sharpless, N. E. and Depinho, R. A. (2006) The mighty mouse: genetically engineered mouse models in cancer drug development. Nat Rev Drug Discov. 9, 741-54. (Pubitemid 44323701)
23. Weiss, B. and Shannon, K. (2003) Mouse cancer models as a platform for performing preclinical therapeutic trials. Curr Opin Genet Dev 13, 84-89. (Pubitemid 36143932)
24. Jacks, T. (1996) Tumor suppressor gene mutations in mice. Annu Rev Genet 30, 603-636. (Pubitemid 27014480)
25. Stringer, J. R., Larson, J. S., Fischer, J. M., Medvedovic, M., Hersh, M. N., Boivin, G. P. and Stringer, S. L. (2005) Modeling variation in tumors in vivo. Proc Natl Acad Sci USA 102, 2408-2413. (Pubitemid 40279389)
26. Hann, B. and Balmain, A. (2001) Building 'validated' mouse models of human cancer. Curr Opin Cell Biol 13, 778-784. (Pubitemid 33042740)
27. Van, D. T. and Jacks, T. (2002) Cancer modeling in the modern era: progress and challenges. Cell 108, 135-144. (Pubitemid 34161134)
28. Berger, M. R. (1999) Is there relevance for anticancer drug development, in relevance of tumor models for anticancer drug development, Chapter 54, Fiebig, H. H., Burger, B. A. (eds.) Karger Publishing, Basel, pp 15-27.
29. Talmadge, J. E., Lenz, B. F., Klabansky, R., Simon, R., Riggs, C., Guo, S., Oldham, R. K. and Fidler, I. J. (1986) Therapy of autochthonous skin cancers in mice with intravenously injected liposomes containing muramyltripeptide. Cancer Res 46, 1160-1163. (Pubitemid 16048248)
30. Schwartz, B., Birk, Y., Raz, A. and Madar, Z. (2004) Nutritional- pharmacological combinations-a novel approach to reducing colon cancer incidence. Eur J Nutr 43, 221-229. (Pubitemid 39222534)
31. Schipper, H., Goh, C. R. and Wang, T. L. (1995) Shifting the cancer paradigm: must we kill to cure? J Clin Oncol 13, 801-807.
32. Schuh, J. C. (2004) Trials, tribulations, and trends in tumor modeling in mice. Toxicol Pathol 32 Suppl 1, 53-66. (Pubitemid 38437568)
33. Seemann, M. D., Beck, R. and Ziegler, S. (2006) In vivo tumor imaging in mice using a state-of-the-art clinical PET/CT in comparison with a small animal PET and a small animal CT. Technol Cancer Res Treat 5, 537-542. (Pubitemid 44606276)
34. Donelli, M. G., Rosso, R. and Garattini, S. (1967) Selective chemotherapy in relation to the site of tumor transplantation. Int J Cancer 2, 421-424.
35. Willmanns, C., Fan, D., O'Brian, C., Radinsky, R., Bucana, C., Tsan, R. and Fidler, I. (1993) Modulation of doxorubicin sensitivity and level of P-glycoprotein expression in human colon carcinoma cells by ectopic and orthotopic environments in nude mice. Int J Oncol 3, 413-422. (Pubitemid 23271909)
36. Bibby, M. C. (2004) Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages. Eur J Cancer 40, 852-857. (Pubitemid 38519764)
37. Kerbel, R. S. (2003) Human tumor xenografts as predictive preclinical models for anticancer drug activity in humans: better than commonly perceived-but they can be improved. Cancer Biol Ther 2, S134-S139.
38. Fidler, I. J. (1986) Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis. Cancer Metastasis Rev 5, 29-49.
39. Tan, M. H., Holyoke, E. D. and Goldrosen, M. H. (1977) Murine colon adenocarcinoma: syngeneic orthotopic transplantation and subsequent hepatic metastases. J Natl Cancer Inst 59, 1537-1544. (Pubitemid 8204819)
40. Balmain, A. (2002) Cancer as a complex genetic trait: tumor susceptibility in humans and mouse models. Cell 108, 145-152. (Pubitemid 34161135)
41. Siemann, D. W. (1987) Satisfactory and unsatisfactory tumor model factors influencing the selection of a tumor model for experimental evaluation, in rodent tumor models in experimental cancer therapy, Kallman, R. F. (ed), Pergamon Press, New York, pp 12-15.